Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
Hennessy
Kevin D
KD
Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, 200 Independence Avenue, SW, Room 442E, Washington, DC 20201, USA.
Green-Hennessy
Sharon
S
Buck
Jeffrey A
JA
Miller
Kay
K
D003156:Community Mental Health Services / Q000191:economics / Q000600:supply & distribution*; D016527:Drug Costs / Q000706:statistics & numerical data; D004363:Drug Utilization; D017048:Health Care Costs / Q000706:statistics & numerical data; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D008484:Medicaid / Q000191:economics* / Q000706:statistics & numerical data*; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use*; D016320:Substance Abuse Treatment Centers / Q000191:economics / Q000600:supply & distribution; D019966:Substance-Related Disorders / Q000191:economics* / Q000534:rehabilitation; D014481:United States
D011619:Psychotropic Drugs